Skip to main content
Top
Published in:

01-12-2025 | Epilepsy | Review

The Development of Epilepsy Following CNS Viral Infections: Mechanisms

Authors: Giulia Savoca, Arianna Gianfredi, Luca Bartolini

Published in: Current Neurology and Neuroscience Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

This review examines the role of different viral infections in epileptogenesis, with a focus on Herpesviruses such as Human Herpesvirus 6 (HHV-6) and Epstein Barr Virus (EBV), Flaviviruses, Picornaviruses, Human Immunodeficiency Virus (HIV), Influenzavirus and Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2).

Recent Findings

A growing literature on animal models, such as the paradigmatic Theiler’s murine encephalomyelitis virus (TMEV) model, and clinical investigations in patients with epilepsy have started to elucidate cellular mechanisms implicated in seizure initiation and development of epilepsy following viral infections. A central role of neuroinflammation has emerged, with evidence of activation of the innate and adaptive immunity, dysregulation of microglial and astrocytic activity and production of multiple cytokines and other inflammatory mediators. Several chronic downstream effects result in increased blood–brain barrier permeability, direct neuronal damage, and modifications of ion channels ultimately leading to altered neuronal excitability and seizure generation.

Summary

Key findings underscore the complex interplay between initial viral infection, neuroinflammation, and later development of epilepsy. Further research is needed to elucidate these mechanisms and develop targeted interventions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
The Development of Epilepsy Following CNS Viral Infections: Mechanisms
Authors
Giulia Savoca
Arianna Gianfredi
Luca Bartolini
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 1/2025
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-024-01393-4

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest